Regeneron Pharmaceuticals, Inc.
REGNBiotechnology
$927.89+13.33%As of Oct 30vs prior close
- Market cap
- $96B
- P/E (TTM)
- 19.8×
- P/E (FY1)
- 15.8×
- Implied growth
- 10.4%
- From 52W high
- 0.00%
- EPS (LTM)
- $45.21
- Revenue (LTM)
- $16.9B
- Net margin
- 28.51%
- Dividend yield
- 0.40%
Nomior Score
74
Discounted QualityTop 6% of the scored universe
Growth50
Quality79
Value76
Momentum60
Resilience60
Growth
+12.78%revenue a year over 9 fiscal years
FY16 $4.9BLTM $16.9B
Connections
Revenue to profitQ3 FY26
38% of revenue became net profit, down 1 pt on a year.
Who owns it
7funds, 4 tracked portfolios